Evolus, Inc. - Common Stock (NQ:EOLS)

5.900 -0.150 (-2.48%)

Streaming Delayed Price Updated: 3:21 PM EST, Jan 6, 2026 Add to My Watchlist

Price and Volume

Volume	909,506
Open	6.110
Bid (Size)	5.890 (1,300)
Ask (Size)	5.900 (1,400)
Prev. Close	6.050
Today's Range	5.810 - 6.128
52wk Range	5.710 - 17.12
Shares Outstanding	54,576,156
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗

December 28, 2025

When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.

Via The Motley Fool

ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗

December 28, 2025

ANI is firing on all cylinders operationally, which makes this exit less about fundamentals and more about portfolio discipline at a moment when expectations might be sky-high.

Via The Motley Fool

Performance

YTD	-12.2%	-12.2%
1 Month	-15.4%	-15.4%
3 Month	-8.2%	-8.2%
6 Month	-35.4%	-35.4%
1 Year	-46.4%	-46.4%

More News

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 14, 2025

From Evolus

Via Business Wire

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Evolus (EOLS) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 06, 2025

Via Benzinga

Evolus Reports Third Quarter 2025 Financial Results

November 05, 2025

From Evolus

Via Business Wire

Evolus to Participate in 2025 Stifel Healthcare Conference

October 28, 2025

From Evolus

Via Business Wire

Evolus to Report Third Quarter Financial Results on November 5, 2025

October 22, 2025

From Evolus

Via Business Wire

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 10, 2025

From Evolus

Via Business Wire

Evolus Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 12, 2025

From Evolus

Via Business Wire

Evolus Announces the Appointment of Tatjana Mitchell as Chief Financial Officer

September 08, 2025

From Evolus

Via Business Wire

Evolus Announces Positive Data From Pivotal Trial for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp

August 25, 2025

From Evolus

Via Business Wire

Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product

August 20, 2025

From Evolus

Via Business Wire

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 08, 2025

From Evolus

Via Business Wire

What's going on in today's session ↗

August 06, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 06, 2025

Via Benzinga

Here are the top movers in Wednesday's session. ↗

August 06, 2025

Via Chartmill

The market is filled with gapping stocks in Wednesday's session. ↗

August 06, 2025

Via Chartmill

Evolus (EOLS) Q2 Revenue Rises 4% ↗

August 06, 2025

Via The Motley Fool

Discover the top movers in Wednesday's pre-market session. ↗

August 06, 2025

Via Chartmill

Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 06, 2025

Via Benzinga

Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket ↗

August 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 05, 2025

Via Benzinga

Frequently Asked Questions

Is Evolus, Inc. - Common Stock publicly traded?

Yes, Evolus, Inc. - Common Stock is publicly traded.

What exchange does Evolus, Inc. - Common Stock trade on?

Evolus, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Evolus, Inc. - Common Stock?

The ticker symbol for Evolus, Inc. - Common Stock is EOLS on the Nasdaq Stock Market

What is the current price of Evolus, Inc. - Common Stock?

The current price of Evolus, Inc. - Common Stock is 5.900

When was Evolus, Inc. - Common Stock last traded?

The last trade of Evolus, Inc. - Common Stock was at 01/06/26 03:21 PM ET

What is the market capitalization of Evolus, Inc. - Common Stock?

The market capitalization of Evolus, Inc. - Common Stock is 322.00M

How many shares of Evolus, Inc. - Common Stock are outstanding?

Evolus, Inc. - Common Stock has 322M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.